Quarterly report pursuant to Section 13 or 15(d)

Schedule of Warrant Activities (Details)

v3.22.2.2
Schedule of Warrant Activities (Details) - Warrant [Member]
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Number of Shares, Outstanding, Beginning balance | shares
Weighted Average Exercise Price, Outstanding, Beginning balance | $ / shares
Aggregate Intrinsic Value, Beginning | $ [1]
Granted | shares 7,083,500
Weighted Average Exercise Price, Granted | $ / shares $ 0.05
Number of Shares, Outstanding, Ending balance | shares 7,083,500
Weighted Average Exercise Price, Outstanding, Ending balance | $ / shares $ 0.05
Weighted Average Remaining Contractual Term in Years, ending. 4 years 3 months 18 days
Aggregate Intrinsic Value, Ending | $ $ 259 [1]
Exercisable, ending balance | shares 7,083,500
Weighted Average Exercise Price, Exercisable | $ / shares $ 0.05
Weighted Average Remaining Contractual Term in Years, Exercisable 4 years 1 month 6 days
Aggregate Intrinsic Value, Ending | $ $ 259 [1]
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $ 0.0866 for our common stock on June 30, 2022.